雙匯發展(000895.SZ)跌超7% 四季度營收和淨利潤雙雙負增長
格隆匯3月31日丨昨晚公佈業績的雙匯發展(000895.SZ)盤中大跌,一度跌7.68%報40.51元,回吐了此前4個交易日的漲幅,最新市值1408億元。財報顯示,2020年營收739.35億元,同比+22.51%;實現歸母淨利潤62.56億元,同比+15.04%。其中,四季度營收/歸母淨利潤181.71/13.17億元,同比分別-0.99%/-11.86%。機構稱,總體看,公司全年收入、利潤端均保持穩健增長。其中豬價維持相對高位是屠宰業務收入增速較高的主要原因,但是生豬出欄量仍處於恢復期,導致屠宰業務開工率仍略有不足,毛利率同比小幅下滑,拖累利潤端增速。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.